达拉单抗-泊马度胺联合超分次全乳腺照射是安全的!

IF 1.2 Q4 ONCOLOGY
Reports of Practical Oncology and Radiotherapy Pub Date : 2024-07-22 eCollection Date: 2024-01-01 DOI:10.5603/rpor.100780
Kamel Debbi, Gokoulakrichenane Loganadane, Louise Roulin, Karim Belhadj, Chahrazed Boukhobza, Amira Saoudi, Noémie Grellier, Yazid Belkacemi
{"title":"达拉单抗-泊马度胺联合超分次全乳腺照射是安全的!","authors":"Kamel Debbi, Gokoulakrichenane Loganadane, Louise Roulin, Karim Belhadj, Chahrazed Boukhobza, Amira Saoudi, Noémie Grellier, Yazid Belkacemi","doi":"10.5603/rpor.100780","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":47283,"journal":{"name":"Reports of Practical Oncology and Radiotherapy","volume":"29 3","pages":"409-411"},"PeriodicalIF":1.2000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321792/pdf/","citationCount":"0","resultStr":"{\"title\":\"Combined daratumumab-pomalidomide and ultra-fractionated whole breast irradiation is safe!\",\"authors\":\"Kamel Debbi, Gokoulakrichenane Loganadane, Louise Roulin, Karim Belhadj, Chahrazed Boukhobza, Amira Saoudi, Noémie Grellier, Yazid Belkacemi\",\"doi\":\"10.5603/rpor.100780\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":47283,\"journal\":{\"name\":\"Reports of Practical Oncology and Radiotherapy\",\"volume\":\"29 3\",\"pages\":\"409-411\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321792/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Practical Oncology and Radiotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/rpor.100780\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Practical Oncology and Radiotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/rpor.100780","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Combined daratumumab-pomalidomide and ultra-fractionated whole breast irradiation is safe!
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.80
自引率
8.30%
发文量
115
审稿时长
16 weeks
期刊介绍: Reports of Practical Oncology and Radiotherapy is an interdisciplinary bimonthly journal, publishing original contributions in clinical oncology and radiotherapy, as well as in radiotherapy physics, techniques and radiotherapy equipment. Reports of Practical Oncology and Radiotherapy is a journal of the Polish Society of Radiation Oncology, the Czech Society of Radiation Oncology, the Hungarian Society for Radiation Oncology, the Slovenian Society for Radiotherapy and Oncology, the Polish Study Group of Head and Neck Cancer, the Guild of Bulgarian Radiotherapists and the Greater Poland Cancer Centre, affiliated with the Spanish Society of Radiotherapy and Oncology, the Italian Association of Radiotherapy and the Portuguese Society of Radiotherapy - Oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信